Manufacturing of active pharmaceutical ingredients and contract-based molecule development services.
Annual revenue $2.0M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Apionex

Apionex is a company based in Mumbai (India). Apionex offers products and services including Hydroquinone and Triclofos Sodium.

  • Headquarter Mumbai, India
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Apionex Pharma Pvt Ltd
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.97 M (USD)
    3.77
    as on Mar 31, 2023
  • Net Profit
    $54.26 K (USD)
    55.75
    as on Mar 31, 2023
  • EBITDA
    $115.57 K (USD)
    54.82
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Apionex

Apionex offers a comprehensive portfolio of products and services, including Hydroquinone and Triclofos Sodium.

Product name locked
Category locked
Primary

Hydroquinone is used as a depigmentation agent in pharmaceutical applications.

Product name locked
Category locked
Locked

Triclofos Sodium is utilized for treating insomnia as a sedative drug in medical contexts.

Funding Insights of Apionex

Premium access

Detailed funding history for Apionex

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Apionex

Investments
Premium access

Investment portfolio details for Apionex

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Apionex

Premium access

Detailed financials for Apionex

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Apionex Comparisons

Apionex Primary company
Description
Manufacturing of active pharmaceutical ingredients and contr...
Location
Mumbai, India
Founded Year
-
Annual Revenue
$1.97 M (USD)
Net Profit
$54.26 K (USD)
EBITDA
$115.57 K (USD)
Employees
Not available
Premium access

Peer comparison for Apionex

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Apionex

Premium access

Detailed competitors of Apionex

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Apionex

Premium access

Complete news archive for Apionex

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Apionex

Apionex is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Annual revenue of Apionex is $1.97M as on Mar 31, 2023.

Apionex is engaged in the manufacturing and supplying of active pharmaceutical ingredients, with development of new molecules undertaken on a contract basis. A focus is placed on delivering value-added services cost-effectively, adhering to regulatory standards and emphasizing innovation and quality. The company is recognized for its RD efforts using advanced technologies, ensuring compliance and building partnerships globally. Products such as Hydroquinone and Triclofos Sodium are produced to meet medical needs, while ethical practices are maintained in operations.

Apionex offers Hydroquinone and Triclofos Sodium.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available